Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
Massage Therapy Foundation Research Grant is sponsored by Massage Therapy Foundation. Larger-scale research grants on massage therapy’s role in health or flexibility; ideally suited for projects integrating AI methods under the Foundation’s AI/ML policy.
Official opportunity description and requirements excerpt:
Research Grant Application – Massage Therapy Foundation Research Grant Application MTF’s 2026 Research Grant and Research Support Award application processes are now open! The Massage Therapy Foundation offers two types of research grants: Research Support Awards (up to $30,000) and Research Grants (over $30,000). Massage Therapy Foundation research grants and awards are awarded to individuals or teams conducting studies that promise to advance our understanding of specific therapeutic applications of massage, public perceptions of and attitudes toward massage therapy, and the role of massage therapy in health care delivery. MTF research grants and awards support high quality, independent research that contributes to the basic science of massage therapy application, including applied research investigating massage therapy as a health/mental health treatment and/or prevention modality. The research grants and awards are available to investigators who have experience in the relevant field of research, and are presently associated with a university, independent research organization, or other institution qualified to act as Sponsoring Organization. MTF Research Support Award (up to $30,000) The 2026 Research Support Award application deadline is February 28, 2026. The maximum award is $30,000 for a one-year project period. 2026 Research Support Award Guidelines >> 2026 Research Support Award Application Instructions >> Research Support Award Ethics Review Form>> MTF Applicant Artificial Intelligence (AI) and Machine Learning Policy>> MTF Research Grant (over $30,000) The 2026 Research Grant LOI application deadline is February 28, 2026. Amount awarded is between $30,000 to $300,000 and must be used in the specific time period for which it has been awarded (can be used over the course of multiple years). 2026 Research Grant Guidelines >> 2026 Research Grant Application Instructions >> Research Grant Ethics Review Form>> MTF Applicant Artificial Intelligence (AI) and Machine Learning Policy>> “The MTF grant is helping me to advance my research aimed at developing effective and innovative strategies to assist caregivers to reduce their stress and enhance their own well-being as they manage the many challenges associated with caring for a loved one who has a serious medical condition. With the help of this grant, our research team collected critical data needed to inform the implementation and adaptation of a massage therapy intervention for caregivers in hospital settings. We plan to use this preliminary data to support a larger federal grant application that will enable us to conduct a larger intervention trial.” MTF Research Support Award Recipient “I believe in the power of massage and its impact on health and wellness. Receiving this grant has helped me to introduce research to the next
Get alerted about grants like this
Save a search for “Massage Therapy Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Research Grant Application – Massage Therapy Foundation Research Grant Application MTF’s 2026 Research Grant and Research Support Award application processes are now open! The Massage Therapy Foundation offers two types of research grants: Research Support Awards (up to $30,000) and Research Grants (over $30,000).
Massage Therapy Foundation research grants and awards are awarded to individuals or teams conducting studies that promise to advance our understanding of specific therapeutic applications of massage, public perceptions of and attitudes toward massage therapy, and the role of massage therapy in health care delivery.
MTF research grants and awards support high quality, independent research that contributes to the basic science of massage therapy application, including applied research investigating massage therapy as a health/mental health treatment and/or prevention modality.
The research grants and awards are available to investigators who have experience in the relevant field of research, and are presently associated with a university, independent research organization, or other institution qualified to act as Sponsoring Organization. MTF Research Support Award (up to $30,000) The 2026 Research Support Award application deadline is February 28, 2026.
The maximum award is $30,000 for a one-year project period. 2026 Research Support Award Guidelines >> 2026 Research Support Award Application Instructions >> Research Support Award Ethics Review Form>> MTF Applicant Artificial Intelligence (AI) and Machine Learning Policy>> MTF Research Grant (over $30,000) The 2026 Research Grant LOI application deadline is February 28, 2026.
Amount awarded is between $30,000 to $300,000 and must be used in the specific time period for which it has been awarded (can be used over the course of multiple years).
2026 Research Grant Guidelines >> 2026 Research Grant Application Instructions >> Research Grant Ethics Review Form>> MTF Applicant Artificial Intelligence (AI) and Machine Learning Policy>> “The MTF grant is helping me to advance my research aimed at developing effective and innovative strategies to assist caregivers to reduce their stress and enhance their own well-being as they manage the many challenges associated with caring for a loved one who has a serious medical condition.
Based on current listing details, eligibility includes: Nonprofits or investigators with sponsoring institutions (universities, independent research organizations). Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $30,000–$300,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is February 28, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
This funding opportunity seeks to enhance operations of a Novel Psychoactive Substance Discovery, Education, and Reporting Institute (NPS Discovery) to rapidly identify and report newly emerging opioids, stimulants, and other drugs which may cause intoxication, impairment, or other adverse effects. Funding Opportunity Number: O-NIJ-2025-172538. Assistance Listing: 16.560. Funding Instrument: CA. Category: ST. Award Amount: Up to $2M per award.
Translating Disruptive New Approach Methodologies (NAMs) into Practice is sponsored by European Commission — Horizon Europe. Expected Impact: This Challenge supports ambitions to maintain and strengthen the health sector in Europe. It will: Accelerate the development and validation of disruptive NAMs for biomedical applications, including medicinal products and medical technologies Support regulatory innovation by providing evidence-based recommendations for the assessment of safety, efficacy, and quality of human health products using NAMs. Enable citizens to benefit from novel technologies that have been assessed through rigorous NAMs that have been validated to can predict potential effects in humans, and Provide industry with a harmonised and standardised NAM-based assessment toolkit that is faster and more flexible. Objective: Specific Objectives This is a two-stage Challenge competition with the ultimate ambition to deliver robust, validated NAMs that constitute a representative model or prototype system i.e. achieve TRL 6 after Stage 2. Applicants should apply to Stage 1 only where there is an outlook of the potential impact in the longer term. Stage 1 – Solution validation and benchmarking Applicants should: Take forward preliminary engagement with regulatory authorities, notified bodies and industry stakeholders Map regulatory, clinical, standardisation (where applicable) and industrial needs, and use this to develop a roadmap for adoption Develop a methodology for performance assessment Deliver small-scale feasibility experiments or modelling Conduct initial performance benchmarking (human relevance, reproducibility, transferability of the approach) Assess ethical, data governance and scalability considerations, as applicable to the given NAM under development. The following milestones need to be achieved at the end of Stage 1: Evidence that the NAM is viable for human relevant biomedical innovation, and addresses the needs of the identified use cases, and Clear commitment from industrial end-users and a well-defined regulatory plan to further develop the NAM in Stage 2. Progress to Stage 2 will be contingent on delivering a full proposal which will be assessed alongside the milestones achieved under Stage 1. Stage 2 – Development and user testing Applicants selected for Stage 2 will further develop and validate a functional, scalable NAM prototype ready for regulatory, industrial, or clinical uptake. Activities must cover a number of the following elements: Benchmarking the NAMs against state-of-the-art animal models and/or human trials Demonstration in relevant application, such as disease modelling, or testing of medicinal products and medical technologies for safety, efficacy, or quality Organisation of consultation meetings/workshops with industrial end users, regulators, CROs (Contract Research Organisations), standard setting bodies or other relevant stakeholders to gather further needs and feedback Engagement with infrastructures for testing and data collection as testing and validation of the NAM outside the developer’s lab Development of regulatory-grade data packages suitable for submission to relevant agencies (e.g. EMA, FDA, OECD), and Documentation on scalability, standardisation, and potential barriers to uptake. During the project’s implementation phase, beneficiaries will be encouraged to consider using the EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) of the European Commission’s Joint Research Centre for aspects of standardisation, automation and validation of in vitro methods. These facilities operate and provide support at the interface between pre-normative research, regulatory sciences and innovation. Scope: New Approach Methodologies (NAMs) have the potential to replace, reduce or refine animal use in the testing96 of medicinal products. Scientific progress in recent decades has delivered several animal-free NAMs that have the potential to transform how we understand human biology and assess the safety, efficacy, and quality testing in the health sector. However, a lack of knowledge, experi Programme areas: Additional EIC activities, The European Innovation Council (EIC), Innovative Europe Official opportunity description and requirements excerpt: EU Funding & Tenders Portal EU Funding & Tenders Portal * Results & Innovation support * SME Self-assessment tool Home Funding Calls for proposals Translating Disruptive New Approach Methodologies (NAMs) into Practice Translating Disruptive New Approach Methodologies (NAMs) into Practice * Conditions and documents EIC Advanced Innovation Challenge (HORIZON-EIC-2026-AIC) HORIZON-EIC HORIZON EIC Grants HORIZON Lump Sum Grant [HORIZON-AG-LS] 26 February 2026 17:00:00 Brussels time This Challenge supports ambitions to maintain and strengthen the health sector in Europe. It will: * Accelerate the development and validation of disruptive NAMs for biomedical applications, including medicinal products and medical technologies * Support regulatory innovation by providing evidence-based recommendations for the assessment of safety, efficacy, and quality of human health products using NAMs. * Enable citizens to benefit from novel technologies that have been assessed through rigorous NAMs that have been validated to can predict potential effects in humans, and * Provide industry with a harmonised and standardised NAM-based assessment toolkit that is faster and more flexible. This is a two-stage Challenge competition with the ultimate ambition to deliver robust, validated NAMs that constitute a representative model or prototype system i.e. achieve TRL 6 after Stage 2. Applicants should apply to Stage 1 only where there is an outlook of the potential impact in the longer term. **Stage 1 – Solution validation and benchmarking** * Take forward preliminary engagement with regulatory authorities, notified bodies and industry stakeholders * Map regulatory, clinical, standardisation (where applicable) and industrial needs, and use this to develop a roadmap for adoption * Develop a methodology for performance assessment * Deliver small-scale feasibility experiments or modelling * Conduct initial performance benchmarking (human relevance, reproducibility, transferability of the approach) * Assess ethical, data governance and scalability considerations, as applicable to the given NAM under development. The following milestones need to be achieved at the end of Stage 1: * Evidence that the NAM is viable for human relevant biomedical innovation, and addresses the needs of the identified use cases, and * Clear commitment from industrial end-users and a well-defined regulatory plan to further develop the NAM in Stage 2. Progress to Stage 2 will be contingent on delivering a full proposal which will be assessed alongside the milestones achieved under Stage 1. **Stage 2 – Development and user testing** Applicants selected for Stage 2 will further develop and validate a functional, scalable NAM prototype ready for regulatory, industrial, or clinical uptake. Activities must cover a number of the following elements: * Benchmarking the NAMs against state-of-the-art animal models and/or human trials Application snapshot: target deadline February 26, 2026; published funding information €12M total budget (~$13M USD) ; up to €300K per project ; ~10 grants expected; eligibility guidance Open to legal entities established in EU Member States and countries associated to Horizon Europe (including EEA/EFTA countries, and other associated third countries). Action type: HORIZON-EIC HORIZON EIC Grants. Additional conditions: "> General conditions 1. Admissibility Conditions: Proposal page limit and layout The call is open for submission by A single legal entity established in a Member State or an Associated Country (‘mono-beneficiary’) if you are a start-up, SME or research performing organisation (university, research or technology organisation, including teams, individual Principal Investigators and inventors). Larger companies (i.e. which do not qualify as SMEs) are not eligible to apply as a single legal... See the official call documentation on the F&T Portal for full eligibility criteria and participation rules. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Application snapshot: target deadline February 28, 2026; published funding information $30,000–$300,000; eligibility guidance Nonprofits or investigators with sponsoring institutions (universities, independent research organizations).
Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
With the help of this grant, our research team collected critical data needed to inform the implementation and adaptation of a massage therapy intervention for caregivers in hospital settings. We plan to use this preliminary data to support a larger federal grant application that will enable us to conduct a larger intervention trial.
” MTF Research Support Award Recipient “I believe in the power of massage and its impact on health and wellness. Receiving this grant has helped me to introduce research to the next generation of researchers: students. This powerful experience has allowed them to grow and gain an understanding they didn’t have before.
The MTF has provided me with an invaluable opportunity. To have funding available for massage is an incredible gift. I am so thankful for the efforts and work of the Foundation.
” MTF Research Support Award Recipient For additional information please contact: Annie LaCroix, MS, LMT, Associate Director – Operations alacroix@massagetherapyfoundation. org Current MTF Research Projects Past Community Service Awards Past Student Case Report Contest Past Practitioner Case Report Contest Massage Therapy Foundation info@massagetherapyfoundation. org
© 2026 Granted AI